Hematology/Oncology and Bone Marrow Transplantation

412-692-7192
412-692-7693 Fax

Lakshmanan Krishnamurti, MD

Director, Comprehensive Hemoglobinopathy Program
Associate Professor


Division of Pediatric Hematology/Oncology/BMT
Children's Hospital of Pittsburgh
3705 Fifth Ave.
Pittsburgh, PA 15213

412-692-7192
412-692-7693 Fax
lakshmanan.krishnamurti@chp.edu
Patient Appointment Information


Education and Training

Medical School:

1987 Naval Hospital, Bombay University, Bombay, India

Residency:

1998 University of Minnesota, Minneapolis, MN

Fellowship:

1997 University of Minnesota, Minneapolis, MN


Memberships
  • American Society of Hematology
  • American Society of Pediatric Hematology/Oncology
  • American Society of Bone Marrow Transplantation
Board Certifications
  • American Board of Pediatrics
  • American Board of Pediatrics, Sub-board of Pediatric Hematology/Oncology
Awards
  • "Ajit Gharpure Award" for excellence in Preventive Medicine and Public Health, Poona University, Pune, India
Publications

Active Research Projects/Grants
  • Principal Investigator, A Phase II/II study of Sildenafil for the treatment of sickle cell disease, associated pulmonary hypertension
  • Principal Investigator, "Western Pennsylvania Sickle Cell Network: An Integrated System of Care for the Enhancement of Newborn Screening Follow-Up"
  • Principal Investigator, "Newborn Screening Follow-Up and comprehensive care for Sickle cell disease in region 3 of Pennsylvania"
  • Site Principal Investigator, "Deferoxamine in sickle cell disease patients with transfusional hemosiderosis"
  • Site Principal Investigator, "Safety of ICL670 in Sickle Cell Patients with Iron Overload"
  • Site Principal Investigator, "Safety of ICA-17043 with or without Hydroxyurea"
  • Site Principal Investigator, "Randomized study of Inhaled Nitric Oxide for the treatment of sickle cell associated vasocclusive pain crises"

Current Research Interests
  • Hemoglobinopathies clinical and molecular epidemiologic aspects
  • Newborn screening and counseling for hemoglobinopathies
  • Novel approaches to hematopoietic stem cell transplantation for hemoglobinopathies
  • Lymphoproliferative disorder following solid organ and bone marrow transplantation
  • Non-myeloablative HSCT for malignant and non-malignant disorders
  • Role of allochimerism in tolerization to transplanted solid organs
  • Role of Bioinformatics systems in clinical care and research in sickle cell disease

Top

For Media Inquiries
Children’s Media Team is available 24 hours a day, seven days a week.
To contact the Media Team:

Monday through Friday, 8:30 a.m.-5 p.m.:
Melanie Finnigan, Manager, Media Relations
National and local media
412-692-7104 or 412-692-5502
Melanie.Finnigan@chp.edu

Marc Lukasiak, Senior Media Specialist
Local media
412-692-7104 or 412-692-7919
Marc.Lukasiak@chp.edu

After hours, weekends and holidays:
Call Children’s operators at 412-692-5325 and ask to have the on-call member of the Media Team paged.